Predicting TKI Efficacy in Cancer Through a Single-Cell-Guided Model of Kinase ActivationA computational system for prioritizing tyrosine kinase inhibitors (TKIs) by integrating single‑cell transcriptional data, advanced computational modeling, and machine‑learning–based scoring to identify tumor‑specific signaling vulnerabilities across the entire tumor microenvironment. |
Tech ID2025-041 College(None) Licensing ManagerInventorsCategories(None) |